BRCA2 Antikörper (N-Term)
Kurzübersicht für BRCA2 Antikörper (N-Term) (ABIN127309)
Target
Alle BRCA2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- This antibody detects BRCA2.
-
Aufreinigung
- Affinity Chromatography.
-
Immunogen
- Synthetic peptide mapping to the N-terminus of Human BRCA2.
-
-
-
-
Applikationshinweise
-
Western Blot: 0.5-4 μg/mL. HeLa cell lysate can be used as a Positive Control.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 0.5 mg/mL
-
Buffer
- PBS pH 7.2, containing 30 % Glycerol, 0.5 % BSA and 0.01 % Thimerosal
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains thimerosal (merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- -20 °C/-80 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at -20 °C or for long term storage (in aliquots) at -70 °C.
-
-
- BRCA2 (Breast Cancer 2, Early Onset (BRCA2))
-
Andere Bezeichnung
- BRCA2 / FANCD1
-
Hintergrund
- BRCA 1 and 2 are breast cancer susceptibility proteins that plays a role in DNA damage, repair, cell cycle progression, transcription and apoptosis, etc. The BRCA1 gene is expressed in numerous tissues, including breast and ovary, and encodes a predicted protein of 1863 amino acids. BRCA2 has been shown to be required for localization of Rad51 to sites of DSBs (double stranded breaks) in DNA. Cells lacking BRCA1 and BRCA2 cannot repair DSBs through the Rad51-dependent process.Synonyms: Breast cancer type 2 susceptibility protein, FACD, Fanconi anemia group D1 protein
-
Gen-ID
- 675
-
NCBI Accession
- NP_000050
-
UniProt
- P51587
-
Pathways
- DNA Reparatur, M Phase, Maintenance of Protein Location
Target
-